Press

Insights

Contact Us

iPlato, a Huma company – home
Insights

/

Making skin health accessible for all: unveiling the challenges in diagnosing skin conditions on darker skin

360 solution for 2021 flu season

July 26, 2021

The skin is the largest organ of the human body and acts as a protective barrier between the external environment and the inside of the body, shielding the internal organs against heat, light, injury and infection. Yet, the journey to diagnose skin conditions, especially on darker skin tones, can be challenging and not well mapped. In a recent study, physicians were presented with 364 images spanning 46 skin diseases and asked to submit up to four differential diagnoses. The physicians were four percentage points less accurate for the diagnosis of images of dark skin as compared to light skin.  

Inherent biases deeply rooted in medical research, literature, and education have led to a healthcare landscape skewed towards lighter skin, often leaving behind those with darker complexions. Doctors diagnose around one-quarter of melanoma cases in Black people when cancer has already spread to nearby lymph nodes. However, amidst these challenges, there are technological advancements, such as AI, that are helping to rectify this imbalance. In May 2024, Autoderm conducted a total of 18,359 analyses through the myGP app and identified 79 cases of melanoma. This equates to about 2-3 melanoma diagnoses per day. Given that approximately 46 melanomas are diagnosed daily across the UK, the cases detected via the myGP app represent about 5% of the total daily melanoma diagnoses in the UK population. 

​

We recognise the need for equitable healthcare solutions for all. Through our partnership with Autoderm, launched in 2023 after years of clinical and AI research, are proud to offer their next generation skin scanner to our community of 3 million users via the myGP app. 

The bias in dermatology towards lighter skin tones is a well-documented issue. From medical textbooks to research studies, most visual references and diagnostic criteria are based on observations of mainly fair-skinned individuals.This bias perpetuates a cycle of misdiagnosis and inadequate treatment for patients with darker skin, which can lead to unnecessary distress and prolonged health issues such as increased itching, dryness, skin thickening and hyperpigmentation. 

​

Autoderm and the myGP app, however, are changing the game! By harnessing the power of AI, Autoderm helps improve diagnostic accuracy of skin conditions across all skin tones. Their approach analyses a diverse search engine of skin images (2 million+), encompassing various ethnicities and skin tones. Their algorithm is constantly evolving and learning along with their growing bank of images. Irrespective of skin tone, myGP users can use the tech to get likely answers quickly, easily and choose how to act on the insight.  

​

​

​

​

​

​

​

​

​

​

​

Press

Insights

Contact Us

iPlato, a Huma company – home

Practice Area

Insights

/

Making skin health accessible for all: unveiling the challenges in diagnosing skin conditions on darker skin

360 solution for 2021 flu season

July 26, 2021

The skin is the largest organ of the human body and acts as a protective barrier between the external environment and the inside of the body, shielding the internal organs against heat, light, injury and infection. Yet, the journey to diagnose skin conditions, especially on darker skin tones, can be challenging and not well mapped. In a recent study, physicians were presented with 364 images spanning 46 skin diseases and asked to submit up to four differential diagnoses. The physicians were four percentage points less accurate for the diagnosis of images of dark skin as compared to light skin.  

Inherent biases deeply rooted in medical research, literature, and education have led to a healthcare landscape skewed towards lighter skin, often leaving behind those with darker complexions. Doctors diagnose around one-quarter of melanoma cases in Black people when cancer has already spread to nearby lymph nodes. However, amidst these challenges, there are technological advancements, such as AI, that are helping to rectify this imbalance. In May 2024, Autoderm conducted a total of 18,359 analyses through the myGP app and identified 79 cases of melanoma. This equates to about 2-3 melanoma diagnoses per day. Given that approximately 46 melanomas are diagnosed daily across the UK, the cases detected via the myGP app represent about 5% of the total daily melanoma diagnoses in the UK population. 

​

We recognise the need for equitable healthcare solutions for all. Through our partnership with Autoderm, launched in 2023 after years of clinical and AI research, are proud to offer their next generation skin scanner to our community of 3 million users via the myGP app. 

The bias in dermatology towards lighter skin tones is a well-documented issue. From medical textbooks to research studies, most visual references and diagnostic criteria are based on observations of mainly fair-skinned individuals.This bias perpetuates a cycle of misdiagnosis and inadequate treatment for patients with darker skin, which can lead to unnecessary distress and prolonged health issues such as increased itching, dryness, skin thickening and hyperpigmentation. 

​

Autoderm and the myGP app, however, are changing the game! By harnessing the power of AI, Autoderm helps improve diagnostic accuracy of skin conditions across all skin tones. Their approach analyses a diverse search engine of skin images (2 million+), encompassing various ethnicities and skin tones. Their algorithm is constantly evolving and learning along with their growing bank of images. Irrespective of skin tone, myGP users can use the tech to get likely answers quickly, easily and choose how to act on the insight.  

​

​

​

​

​

​

​

​

​

​

​

Press

Insights

Contact Us

Insights

/

360 solution for 2021 flu season

360 solution for 2021 flu season

July 26, 2021

The 2021 flu season is soon upon us. With 35 million people to vaccinate for seasonal flu, people over 50 to potentially receive a Covid booster, a Delta variant that is very much alive, a long Covid challenge, and a huge backlog of interventions pending – this flu season will be more challenging than ever.


The challenge(s)

  • Vaccinating 35 million people in England for seasonal flu
  • Continue vaccination programme, including potential boosters for the over 50 population
  • Treating long covid, which requires remote support to large numbers of people
  • Growing numbers of people presenting in urgent care, particularly with mental health issues
  • Massive backlog in procedures and preventions, including cancer screening and health checks.
  • An exhausted clinical workforce that has been battling back several fires since March 2020


The Solution

It would be wrong to suggest that digital technology can address all these challenges all by itself. However, after supporting our vast primary care network of users and commissioners over the last 17 months, we have developed an overall solution that addresses most of the urgent challenges.


How to quickly engage large but selected parts of the population around vaccination?


iPLATO’s core expertise in population health engagement has seen us consistently supporting successful flu vaccination programmes in the UK. In 2020, we managed more than 180 million transactions on our platform; several million of those relating directly to flu interventions. For Flu 21, we are expanding our existing flu solution to include web-based booking; completing the circle of vaccination support as we approach the autumn and winter months.


We now offer not just targeted and personalised SMS campaigns, selective appointment booking on the myGP App, and a chatbot for patient education, but also web-based booking to streamline invitation, booking, and follow-up capabilities. This 360 solution will allow us to go further in support of vaccination programmes throughout the community, both within GP practices and in larger, dedicated vaccination centres; providing personalised patient engagement campaigns at the practice, PCN, CCG, NHS region, or national level.


How to support people living with long term conditions and long Covid?

iPLATO Research and Development is coming out with two innovations in time for Flu 21.

First, we are adding two-way documents and images to our desktop plugin feature – a free platform feature, touchingly dubbed ‘Buddy’. Buddy already supports video and SMS consultations, but the new release will allow GP practices to save on the cost of text messages, by sending messages to myGP app users, completely free of charge.


Second, we are adding another free tool to the platform in the shape of Patient Questionnaires (PQs). PQs are templated data collection forms sent to as many patients as you want. We are starting with Covid-relevant templates including BMI (weight and height), blood pressure, ethnicity, smoking status, anxiety, body temperature, pulse, oxygen saturation and respiratory rate.


Both Buddy and Patient Questionnaires include SNOMED (or Read) Coding functionality to streamline the interaction with EMIS or SystmOne. Not only does this type of digital consultation technology allow clinicians to work from home; it has proven to increase employee satisfaction. In short – you asked for them and we have delivered them!


How to reduce pressure on urgent care and allow practices to tackle their growing backlogs?

Increasing capacity in primary care and reducing pressure on urgent care is at the heart of every single thing iPLATO does, builds, and advocates for.


We achieve this in our base platform through our easy-to-use SMS appointment reminder/cancellation capability, which allows practices to reallocate appointments in real time.


Additionally, our care-navigation chatbot (pre-GP) reduces unnecessary GP appointments by recognising key words to safely signpost alternatives including pharmacy, practice nurse, patient education, and local services. This premium feature helps stave off unnecessary appointments and allows clinicians to focus on the most urgent patients first.


Finally – as the covid vaccination programme has shown since the beginning of the year – successful prevention including, increased uptake of vaccination, ultimately reduces pressure on urgent care. In addition to engagement around vaccination, the iPLATO team has unique experiences in increasing uptake of cancer screening, mental health services and health checks – just to mention a few.


The results

iPLATO’s commitment to delivering evidence-based digital solutions is unparalleled in British primary care. In recent years we have supported randomised control trials on patient engagement interventions across breast, cervical, and bowel cancer as well as NHS health checks.


Whether you are a single GP practice, a PCN, a CCG or an NHS region, we will base your solution on the kind of firm evidence that patients and clinicians deserve. The kind that has been gathered, tested, challenged, and fine-tuned over nearly of decade of serving British GP services. We are not the new kids on the block. We are a long-time trusted partner of the NHS. A British business serving the communities in which we live.


So we say. “Bring it on, Flu Season 2021. iPLATO and our partner practices are ready for you.”